Skip to main content
. 2004 Fall;26(1):57–73.

Figure 9. Medicaid Payment Per Recipient for Central Nervous System (CNS) Drugs for 29 SMRF States, by Basis of Eligibility and CNS Drug Group: 1998.

Figure 9

Payment Per Disabled Recipient for Anti-Psychotics was Much Higher Than for Other CNS Drug Groups in the 29 SMRF States

  • Payment per recipient for anti-psychotics for the disabled ($1,188) was nearly three times the amount for the aged ($443) and children ($438) and nearly five times the amount for adults ($215). This finding is the result of at least two major factors: payment and utilization. Payment per prescription for anti-psychotics for the disabled was very high (Figure 7). Also, utilization of anti-psychotics by the disabled was also very high (Figure 8).
  • Payment per recipient for anti-depressants was also higher for the disabled than for any other basis of eligibility group. However, the difference for anti-depressants by basis of eligibility was smaller than for anti-psychotics, ranging from $223 for children to $417 for the disabled.
  • Compared to other CNS drugs, anti-anxiety and hypnotic drugs were relatively inexpensive per recipient at $173 or less. Per recipient expenditures for anti-anxiety drugs were slightly higher for the disabled and aged than for adults and children. In contrast, payment per recipient for hypnotics was slightly higher for adults and children than for the disabled and aged.